return to corporate website
Menu
Return to
www.noxopharm.com
Home
About Us
About Noxopharm
Board of Directors
Management Team
Scientific Advisors
Corporate Governance
Company Constitution
Sustainability
Noxopharm History
Research and Clinical Programs
Research and Clinical Programs
About Pharmorage
Investor Centre
Share Price
ASX Announcements
Why Invest in Noxopharm
Presentations & Interviews
Annual Reports
Financial Reports
Analyst Reports
Investor Fact Sheet
Investor FAQs
Upcoming Events
Privacy Policy
Share Registry Information
Media Centre
Overview
Newsletters
Coverage
Investor Videos
NOX Insights
Noxopharm Podcasts
Contact Us
Contact Us
Partnering
Working at Noxopharm
Newsletter Email Alerts
ASX Announcements Email Alerts
Investor Centre
Home
>
Investor Centre
>
ASX Announcements
Share Price
ASX Announcements
Why Invest in Noxopharm
Presentations & Interviews
Annual Reports
Financial Reports
Analyst Reports
Investor Fact Sheet
Investor FAQs
Upcoming Events
Privacy Policy
Share Registry Information
ASX Announcements
Filter by Year:
2022
2021
2020
2019
2018
2017
2016
20-Jul-2020
Data Shows Idronoxil Holds Key to Problem of COLD Cancers
14-Jul-2020
Noxopharm July 2020 Newsletter Released
14-Jul-2020
Letter to Shareholders - Extraordinary General Meeting
14-Jul-2020
Notice of Extraordinary General Meeting/Proxy Form
8-Jul-2020
Corporate Presentation for the Reach Markets Virtual Event
3-Jul-2020
Ceasing to be a substantial holder
29-Jun-2020
Change of Director's Interest Notice - FB
22-Jun-2020
Change in substantial holding - amended
22-Jun-2020
Change in substantial holding
22-Jun-2020
Noxopharm Chair Letter to Shareholders
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
Next
